Clinical trial
(18)Fluorodeoxyglucose Positron Emission Tomography in Patients With Fabry Disease
NCT00005111 is registered in ClinicalTrials.gov with National Institute of Neurological Disorders and Stroke (NINDS) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- (18)Fluorodeoxyglucose Positron Emission Tomography in Patients With Fabry Disease
- Lead sponsor
- National Institute of Neurological Disorders and Stroke (NINDS)
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 30, 2000
- Completion date
- March 31, 2001
- Enrollment
- 24
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
fabry disease, healthy